Clive Brown
Chief Tech/Sci/R&D Officer bei OXFORD NANOPORE TECHNOLOGIES PLC
Vermögen: 3 Mio $ am 31.03.2024
Profil
Clive G. Brown bekleidet die Position des Chief Technology Officer & Director bei Oxford Nanopore Technologies Plc. In der Vergangenheit war Clive G. Brown als Direktor für Informationstechnologie bei Solexa Ltd., als Direktor bei Oxford GlycoSciences Plc, als Berater beim Wellcome Trust Sanger Institute und als Berater bei Glaxo Wellcome, Inc. tätig. Clive G. Brown erwarb einen Bachelor-Abschluss an der Universität York.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
| 11.01.2024 | 1 720 213 ( 0,20% ) | 3 Mio $ | 31.03.2024 |
Aktive Positionen von Clive Brown
| Unternehmen | Position | Beginn |
|---|---|---|
| OXFORD NANOPORE TECHNOLOGIES PLC | Chief Tech/Sci/R&D Officer | 01.07.2008 |
Ehemalige bekannte Positionen von Clive Brown
| Unternehmen | Position | Ende |
|---|---|---|
| The SCO Group Ltd. | Director/Board Member | - |
| Glaxo Wellcome, Inc. | Corporate Officer/Principal | - |
Oxford GlycoSciences Plc
 Oxford GlycoSciences Plc Pharmaceuticals: MajorHealth Technology Oxford Glycosciences Plc provides biopharmaceutical products. The company develops and manufactures novel products for the diagnosis and treatment of human disease. Its products include bayer, pioneer hi-breddupont, medarex, genmab, glaxosmithkline, neogenesis and pfizer. It was founded in 1988. The company is headquartered in Abingdon, UK. | Corporate Officer/Principal | - |
Solexa Ltd.
 Solexa Ltd. Medical SpecialtiesHealth Technology Solexa Ltd. was a developer of instruments for analyzing genes in the process of drug development. It's research methods have included DNA sequencing, gene expression, genotyping and micro-RNA analysis to allow scientists to analyze individual genomes for drug development and personalized medicine. The company was headquartered in Saffron Walden, UK. | Chief Tech/Sci/R&D Officer | - |
Wellcome Trust Sanger Institute
 Wellcome Trust Sanger Institute BiotechnologyHealth Technology Wellcome Trust Sanger Institute provides genomic research services. It also provides research in the areas of cancer, agaeing, somatic mutation, cellular genetics, human genetics, infection genomics, and malaria. The company was founded in October 1993 and is headquartered in Cambridge, the United Kingdom. | Corporate Officer/Principal | - |
Ausbildung von Clive Brown
| The University of York | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| OXFORD NANOPORE TECHNOLOGIES PLC | Electronic Technology |
| Private Unternehmen | 5 |
|---|---|
Oxford GlycoSciences Plc
Oxford GlycoSciences Plc Pharmaceuticals: MajorHealth Technology Oxford Glycosciences Plc provides biopharmaceutical products. The company develops and manufactures novel products for the diagnosis and treatment of human disease. Its products include bayer, pioneer hi-breddupont, medarex, genmab, glaxosmithkline, neogenesis and pfizer. It was founded in 1988. The company is headquartered in Abingdon, UK. | Health Technology |
Solexa Ltd.
Solexa Ltd. Medical SpecialtiesHealth Technology Solexa Ltd. was a developer of instruments for analyzing genes in the process of drug development. It's research methods have included DNA sequencing, gene expression, genotyping and micro-RNA analysis to allow scientists to analyze individual genomes for drug development and personalized medicine. The company was headquartered in Saffron Walden, UK. | Health Technology |
Wellcome Trust Sanger Institute
Wellcome Trust Sanger Institute BiotechnologyHealth Technology Wellcome Trust Sanger Institute provides genomic research services. It also provides research in the areas of cancer, agaeing, somatic mutation, cellular genetics, human genetics, infection genomics, and malaria. The company was founded in October 1993 and is headquartered in Cambridge, the United Kingdom. | Health Technology |
| Glaxo Wellcome, Inc. | Health Technology |
| The SCO Group Ltd. |
